Abstract:A liver-on-a-chip model is an advanced complex in vitro model (CIVM) that incorporates different cell types and extracellular matrix to mimic the microenvironment of the human liver in a laboratory setting. Given the heterogenous and complex nature of liver-on-a-chip models, brightfield and fluorescence-based imaging techniques are widely utilized for assessing the changes occurring in these models with different treatment and environmental conditions. However, the utilization of optical microscopy techniques for structural and functional evaluation of the liver CIVMs have been limited by the reduced light penetration depth and lack of 3D information obtained using these imaging techniques. In this study, the potential of both labelled as well as label-free multimodal optical imaging techniques for visualization and characterization of the cellular and sub-cellular features of a liver-on-a-chip model was investigated. (1) Cellular uptake and distribution of Alexa 488 (A488)-labelled non-targeted and targeted antisense oligonucleotides (ASO and ASO-GalNAc) in the liver-on-a-chip model was determined using multiphoton microscopy. (2) Hyperspectral stimulated Raman scattering (SRS) microscopy of the C-H region was used to determine the heterogeneity of chemical composition of circular and cuboidal hepatocytes in the liver-on-a-chip model in a label-free manner. Additionally, the spatial overlap between the intracellular localization of ASO and lipid droplets was explored using simultaneous hyperspectral SRS and fluorescence microscopy. (3) The capability of light sheet fluorescence microscopy (LSFM) for full-depth 3D visualization of sub-cellular distribution of A488-ASO and cellular phenotypes in the liver-on-a-chip model was demonstrated. In summary, multimodal optical microscopy is a promising platform that can be utilized for visualization and quantification of 3D cellular organization, drug distribution and functional changes occurring in liver-on-a-chip models, and can provide valuable insights into liver biology and drug uptake mechanisms by enabling better characterization of these liver models.

Multimodal imaging of a liver-on-a-chip model using labelled and label-free optical microscopy techniques

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Hydrogel Microfluidic‐based Liver‐on‐a‐chip: Mimicking the Mass Transfer and Structural Features of Liver

Intravital Observation of High-Scattering and Dense-Labeling Hepatic Tissues Using Multi-Photon Fluorescence Microscopy

Multi-modal on-chip nanoscopy and quantitative phase image reveals the morphology of liver sinusoidal enodthelial cells

State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC.

Liver-on-a-Chip Integrated with Label-Free Optical Biosensors for Rapid and Continuous Monitoring of Drug-Induced Toxicity

Imaging complex organ-on-chip systems

Liver Spheroids on Chips as Emerging Platforms for Drug Screening

Liver-on-chips for drug discovery and development

Dissecting Acute Drug‐Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver‐On‐A‐Chip Model

Quantitative assessment of hepatic steatosis using label-free multiphoton imaging and customized image processing program

Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review

Construction and Application of 3D Microfluidic Liver-On-A-Chip

Multimodal nonlinear optical imaging of obesity-induced liver steatosis and fibrosis

A microvascularized in vitro liver model for disease modeling and drug discovery

Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip

Advanced Liver-on-a-Chip Model for Evaluating Drug Metabolism and Hepatotoxicity

Customizable Microfluidic Origami Liver‐on‐a‐Chip (oLOC)

Advances in Optical Microscopic Imaging for Visualizing Liver Immunology In vivo